An oncology-focused company with advanced-stage diagnostic tech and a promising antibody-based cancer treatment pipeline. Ticker symbol: BUX.c
Global
Joined July 2014
- Tweets515
- Following282
- Followers525
- Likes396
Pinned Tweet
Looking to #invest in #Biotech?
#BioMarkDiagnostics is a leader in next-gen #cancer diagnostics using #metabolites. We are developing proprietary, non-invasive, highly accurate solutions to cost-effectively detect cancer in the very early stages when most cancers can be cured.
Lung Foundation says federal government must implement cancer screening to save 12,000 lives
lnkd.in/gYZQ738S
#Asbestos
In the past, asbestos fibres were used in thermal heating and acoustic insulation methods in homes and workplaces. Since the discovery that the silicate fibres in asbestos can lead to a lifetime of lung damage and #lungcancers.
Medulloblastoma is the most common type of brain cancer in children. These tumors are known to be aggressive growing quickly and has the potential to metastasize to other areas of the body.
genengnews.com/topics/cancer…
Relapsed and refractory tumors are especially challenging after the standard treatments of surgery, radiation, and chemotherapy have failed.
New antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a protein that enables #cancer cells to multiply and spread, was well tolerated & helped to stabilize the disease.
#cardiac #biomarkers market is expected to register a CAGR of 16.36% during the forecast period and is expected to hit USD 4236.02 Million by 2027.
More Details@ lnkd.in/dZ7gX6b6
Key Players
@NovartisOncology Switzerland
@Quidel
@RANDOXLABORATORIES
@TrivitronHealthcare
@JohnsonandJohnson
@Abbott
@SiemensHealthcare Pvt. Ltd.
@BioRadLaboratories,
@DanaherCorporation
@BiomarkDx
#cardiology #medicine #novartis #healthcare #health #hearthealth #mrfr
(BioMark’s assay advantages include low cost, minimally invasive, low false positives and leverages existing lab infrastructure)
lnkd.in/g5nu9_uP
The Company’s initial focus beyond a general cancer red alert tool is on diagnostics for lung cancer, with plans to expand into breast, pancreatic, thyroid, and glioblastoma cancers.
CSE Symbol: BUX | FSE Symbol: 20B | OTCMKTS Symbol: BMKDF
Lung Cancer Metabolite Panel – Early detection of lung cancer in #highriskpopulations and complement Low dose CT screening for lung cancer.
Below is an abstract* that provides a potential market impact of our diagnostic test success for this application.
How do doctors diagnose lung cancer?
When lung cancer is suspected, patients typically have a CT scan, MRI, or PET/CT scan to produce a detailed image of their lungs. If a mass is detected, either a fine needle biopsy, core needle biopsy, bronchoscopy or endobronchial ultrasound.
What are the symptoms of lung cancer?
More common symptoms include a cough that does not go away, trouble breathing, chest discomfort, wheezing, hoarseness, and streaks of blood in the mucus. Loss of appetite, weight loss for no reason, and unusual tiredness.
What are the risk factors for lung cancer?
1) 90 % of lung cancers are caused by cigarette smoke.
2) Exposure to second-hand smoke
3) Radiation therapy
4) Exposure to asbestos, radon, chromium, nickel, arsenic, soot, or tar.
5) Air pollution
6) Family history of lung cancer
What are the different types of lung cancer?
Lung cancer develops in the tissue of the lung, usually in the cells that line the air passages.
There are several types of lung cancer:
-Non-small cell lung cancer
-Small cell lung cancer
-Mesothelioma
⬇️🫁⬇️
Small cell lung cancer — Small cell lung cancer also is named for the size of the cells when viewed under a microscope. Affecting approximately 15 percent of lung cancer patients, it typically starts in the bronchial passages.